Long COVID Severity Linked to White Blood Cell Count

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 29, 2025.

By Dennis Thompson HealthDay Reporter

WEDNESDAY, Jan. 29, 2025 -- A simple blood test might determine which patients are at risk for long COVID, a new study says.

Higher levels of leukocytes – a form of white blood cell – are associated with more severe symptoms of long COVID among older women, researchers reported in a new study published Jan. 29 in the journal Menopause.

“Our findings suggest that leukocyte count, a well-standardized, stable, widely available, and inexpensive clinical marker of inflammation, is an independent predictor of future (long COVID) severity in postmenopausal women,” the research team led by Ted Ng, an assistant professor with the Rush Institute for Healthy Aging at Rush University Medical Center in Chicago, concluded.

For the study, researchers analyzed blood samples taken from more than 1,200 women who participated in a COVID study between June 2021 and February 2022.

More than a third (36%) of the women suffered from long COVID symptoms, including memory problems (13%), “brain fog” (12%), or confusion or difficulty thinking or concentrating (11%), results show.

Of those women, 75% had two or more long COVID symptoms, researchers added.

Women with higher leukocyte counts tended to have more of these symptoms, and their symptoms tended to be more severe, researchers found.

“These findings are consistent with evidence showing that elevated inflammatory markers during or after COVID-19 infection are associated with subsequent (long COVID) severity and (long COVID)-associated symptoms,” researchers wrote.

One theory of long COVID is that a person’s initial infection causes heavy inflammation that does long-term damage to tissues and organs, resulting in lasting symptoms, researchers noted.

However, these results also might mean that the women were suffering from low-level inflammation prior to their COVID infection, researchers said. That existing inflammation could have made the disease even worse.

Further study is needed to better tease out the connections between long COVID and inflammation, and to verify the link between white blood cell counts and long COVID risk, researchers said.

Long COVID “significantly affects quality of life, often leading to severe disability,” Dr. Monica Christmas, associate medical director for The Menopause Society, said in a news release.

“This effect is particularly pronounced in women, who already experience higher rates of cognitive impairment after menopause,” added Christmas, who was not involved in the initial study. “By understanding underlying factors, we can better address these challenges and work to mitigate the cascade of symptoms that follow.”

Sources

  • The Menopause Society, news release, Jan. 29, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-01-30 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords